It is used to control bleeding by promoting clot formation.
Vitamin K is essential for the synthesis of clotting factors II, VII, IX, and X and is used to treat bleeding due to Vitamin K deficiency and in salicylate poisoning with hemorrhagic complications.
Examples of vasoconstrictors include desmopressin and adrenochrome monosemicarbazone.
Hemorrhage is a stress on the cardiovascular system that results in decreased loading of the heart, decreased blood pressure, and decreased perfusion pressure for tissue blood flow.
A collagen plug is a localized hemostatic agent that aids in stopping bleeding by providing a matrix for clot formation.
They are used for topical, absorbable, quick & effective control of capillary or small vessel bleeding.
To apply pressure and restrict blood flow to the affected area.
Electrocautery and electrocoagulation.
AHF, or antihemophilic factor, is prepared from plasma and administered IV; it is indicated for use along with fibrinogen in hemophilia A and AHG deficiency.
Silver nitrate acts as a chemical cautery.
It obscures the operative field, causes shock, leads to tissue anoxia (especially of the brain and myocardium), delays wound healing, increases the risk of infection, and prevents proper coaptation of wound edges.
A hemostatic dressing is a material applied to a wound to promote blood clotting and control bleeding.
Fibrinogen, derived from human plasma, is infused IV to control bleeding in hemophilia, antihemophilic globulin deficiency, and acute fibrinogenic states.
Adrenaline causes vasoconstriction.
Thrombin converts fibrinogen to fibrin, aiding in clot formation.
Using gauze sponge or digital compression for 5-10 minutes to stop bleeding.
Systemic hemostatic agents, also known as coagulants, can be administered orally (PO), intravenously (IV), or intramuscularly (IM).
They primarily work through vasoconstriction and platelet aggregation.
Crushing
Ligation
Hemopatch is a type of collagen-based hemostatic dressing designed to enhance hemostasis.
A hemostatic matrix is used to provide a scaffold for clot formation and to facilitate hemostasis.
Local hemostatic agents and systemic hemostatic agents.
Ethamsylate is used to correct abnormalities of platelet adhesion.
Tannic acid, alum, and ferrous sulfate are examples of astringents that precipitate proteins.
Fibrin sealant provides a meshwork to promote clotting.
Gelatin provides a physical matrix for clot formation.
Microfibrillar collagen promotes platelet adhesion.
Calcium alginate dressing provides calcium for clot formation.
Cellulose strips provide a matrix to initiate clot formation.
